Gender-Related Differences of Tachykinin NK₂ Receptor Expression and Activity in Human Colonic Smooth Muscle

Area of Science:

• Gastroenterology and Pharmacology
• Neuroscience and Receptor Biology

Background:

• The tachykinin NK2 receptor (NK2R) is vital for gastrointestinal motility, activated by neurokinin A (NKA).
• Previous findings suggest gender-specific efficacy of NK2R antagonists like ibodutant in diarrhea-predominant irritable bowel syndrome (IBS-D).

Purpose of the Study:

• To investigate potential gender differences in the expression and activity of NK2 receptors in human colonic smooth muscle.
• To explore the influence of gender on NK2R signaling pathways and the potency of NK2R antagonists.

Main Methods:

• In vitro functional studies on human colonic muscle strips assessing contractile responses to NKA and a selective NK2R agonist.
• Evaluation of ibodutant's antagonistic potency and investigation of NK2R signaling pathways using second messenger inhibitors.
• Western blot and fluorescent immunohistochemistry to determine NK2R protein expression and localization.

Main Results:

• Greater NK2R-mediated contractility and higher ibodutant potency were observed in female colonic smooth muscle compared to males.
• NK2R expression increased with age in females, but not in males; signaling pathways involved Rho kinase and protein kinase C.
• No significant gender differences were found in the distribution of NK2 receptors within the human colon.

Conclusions:

• Significant gender-based variations exist in human colonic NK2 receptor activity, expression patterns, and antagonist efficacy.
• These findings underscore the importance of considering gender as a critical factor in the therapeutic development of NK2 receptor-targeting drugs.
• Understanding these gender distinctions may help explain differential responses to IBS-D treatments and guide future drug design.